Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 23598479)

1.

Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.

Pagliusi S, Leite LC, Datla M, Makhoana M, Gao Y, Suhardono M, Jadhav S, Harshavardhan GV, Homma A.

Vaccine. 2013 Apr 18;31 Suppl 2:B176-83. doi: 10.1016/j.vaccine.2012.11.060. Review.

PMID:
23598479
2.

Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.

Pagliusi S, Makhoana M, Datla M, Leite L, Hendriks J, Gholami A, Huang W, Gao Y, Jadhav S, Harshavardhan GV, Wu Y, Suhardono M, Homma A.

Vaccine. 2013 Jun 28;31(31):3111-5. doi: 10.1016/j.vaccine.2013.04.082. Epub 2013 May 15.

PMID:
23684836
3.

Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.

Jadhav S, Gautam M, Gairola S.

Clin Microbiol Infect. 2014 May;20 Suppl 5:37-44. doi: 10.1111/1469-0691.12568. Epub 2014 Mar 7. Review.

4.

Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.

Pagliusi S, Rustan R, Huang W, Nguyen T; DCVMN Executive Committee.

Vaccine. 2014 Nov 12;32(48):6325-9. doi: 10.1016/j.vaccine.2014.05.075. Epub 2014 Jun 9.

5.

The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.

Jadhav S, Datla M, Kreeftenberg H, Hendriks J.

Vaccine. 2008 Mar 20;26(13):1611-5. doi: 10.1016/j.vaccine.2008.01.034. Epub 2008 Feb 6. Review.

PMID:
18294742
6.
7.

Technology transfer in human vaccinology: a retrospective review on public sector contributions in a privatizing science field.

Hendriks J.

Vaccine. 2012 Sep 28;30(44):6230-40. doi: 10.1016/j.vaccine.2012.07.087. Epub 2012 Aug 14. Review.

PMID:
22902679
8.
9.

Better vaccines for healthier life. Part II. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.

Pagliusi S, Tippoo P, Sivaramakrishnan V, Nguyen T; DCVMN Executive Committee.

Vaccine. 2014 Nov 12;32(48):6330-5. doi: 10.1016/j.vaccine.2014.05.076. Epub 2014 Jun 9.

10.

Vaccinology capacity building in Europe for innovative platforms serving emerging markets.

Hendriks J, Holleman M, Hamidi A, Beurret M, Boog C.

Hum Vaccin Immunother. 2013 Apr;9(4):932-6. doi: 10.4161/hv.23163. Epub 2013 Apr 1.

11.
12.

Vaccine development and deployment: opportunities and challenges in India.

Gupta SS, Nair GB, Arora NK, Ganguly NK.

Vaccine. 2013 Apr 18;31 Suppl 2:B43-53. doi: 10.1016/j.vaccine.2012.11.079. Review.

PMID:
23598492
13.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Perdue ML, Bright RA.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080. Review.

14.
15.

The role of emerging manufacturers in access to innovative vaccines of public health importance.

Milstien JB, Kaddar M.

Vaccine. 2010 Feb 25;28(9):2115-21. doi: 10.1016/j.vaccine.2009.12.036. Epub 2009 Dec 29.

PMID:
20044054
16.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
17.

Availability of quality vaccines: the industrial point of view.

Vandersmissen W.

Vaccine. 1992;10(13):955-7.

PMID:
1471420
18.

Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.

Jadhav SS, Gautam M, Gairola S.

Biologicals. 2009 Jun;37(3):165-8. doi: 10.1016/j.biologicals.2009.02.009. Epub 2009 Mar 26.

PMID:
19328010
19.

Vaccine production, distribution, access, and uptake.

Smith J, Lipsitch M, Almond JW.

Lancet. 2011 Jul 30;378(9789):428-38. doi: 10.1016/S0140-6736(11)60478-9. Epub 2011 Jun 12.

20.

Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.

Beurret M, Hamidi A, Kreeftenberg H.

Vaccine. 2012 Jul 13;30(33):4897-906. doi: 10.1016/j.vaccine.2012.05.058. Epub 2012 Jun 6. Review.

PMID:
22683521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk